Rare Disease Therapies Gain Momentum With Regulatory Support and Continued Market Growth
The landscape for rare disease treatments appears to be evolving rapidly, thanks to a confluence of regulatory momentum and a booming market forecast. Statements from key federal figures in recent...
2025 Chambers USA Guide Honors Standout Knobbe Martens Partners and Practices
Firm ranks highly in life sciences, patent litigation, patent prosecution, and trademarks, copyrights and trade secrets, recognized for “five-star” client service IRVINE, Calif. & SEATTLE, June 6, 2025 – Knobbe Martens...
Johnson & Johnson Study Shows Promise for the Treatment and Potential Cure of Multiple Myeloma
On June 3, 2025, the Journal of Clinical Oncology published a study funded by Johnson & Johnson, which showed that one-third of patients with relapsed/refractory multiple myeloma who were treated...